Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-09-21

Clinical Trial Update: Clinical Study to Investigate the Safety and Effectiveness of RECELL for Repigmentation of Stable Vitiligo Lesions [NA]

View source ↗

Summary

A clinical study evaluating RECELL for repigmentation of stable vitiligo lesions has completed, and the results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RECELL (Autologous cell suspension)

Snippet

Sponsor: Avita Medical | Conditions: Vitiligo | NA | Status: COMPLETED | Results posted: 2023-09-21